Wei Gu

1.3k citations
40 papers · 1.0k indexed · h-index 19
Topics
RNA modifications and cancer (9 papers)Cancer-related molecular mechanisms research (8 papers)Glycosylation and Glycoproteins Research (7 papers)
Journals
Journal of Biological ChemistrySHILAP Revista de lepidopterologíaPLoS ONE
Partner nations
ChinaJapanUnited States

In The Last Decade

Wei Gu

38 papers receiving 1.0k citations

Peers

Wei Gu
Comparison fields: 5 of 97
  • Molecular Biology 768
  • Cancer Research 332
  • Immunology 281
  • Epidemiology 105
  • Cell Biology 105
Replace Luke W. Thomas with:
Luke W. Thomas United Kingdom
Emily N. Chin United States
Katarzyna M. Grzes United Kingdom
Fang Zhao China
Juliana J. Conkright United States
Shaozhong Dong China
Eric M. Jacobson United States
Mariana Cooke United States
Ulrike Rennefahrt Germany
Satya Kuchimanchi United States
Wei Gu relative to Luke W. Thomas United Kingdom Luke W. Thomas's profile →
Citations per field
00.5×1.5×2.0×
Luke W. Thomas · 1×
Citations per year

Countries citing papers authored by Wei Gu

Since Specialization
Citations

This map shows the geographic impact of Wei Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Gu more than expected).

Fields of papers citing papers by Wei Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Gu. The network helps show where Wei Gu may publish in the future.

Co-authorship network of co-authors of Wei Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Gu. A scholar is included among the top collaborators of Wei Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Gu. Wei Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 3
4 45
5 2
6 16
7 59
8 37
9 25
10 53
11 4
12 5
13 40
14 20
15 6
16 1
17 58
18 3
19 75
20 39

About Wei Gu

Wei Gu is a scholar working on Cancer Research, Aging and Developmental Biology, having authored 40 papers that have together received 1.0k indexed citations. Recurring topics across this work include RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (8 papers) and Glycosylation and Glycoproteins Research (7 papers). The work is most often cited by research in Cancer Research (332 citations), Immunology (281 citations) and Molecular Biology (768 citations). Wei Gu has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Jianguo Gu, Tomohiko Fukuda, Tomoya Isaji, Surong Fang, Zhenhua Yang, Yuguang Du, Yan Tan, Xiaomei Li, Jue Wang and Yoshinobu Kariya. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026